EUVIMEDEuropean Health Evidence
Uhr 10/10Sources Journal Tree
Easy Demo

Lokaler Crossref-Datenbestand · journal-article

Case Report: Single-cell transcriptomic profiling of a pediatric ALK-negative gastric inflammatory myofibroblastic tumor

Jusen Nong, Weikun Li, Bo Shi

Frontiers in Immunology · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal neoplasm, approximately 50% of which harbor ALK rearrangements. ALK-negative gastric IMT (G-IMT) in pediatric patients is exceptionally rare and poorly characterized. We report a 6-year-old male with fever, melena, and severe anemia (Hb 30 g/L). Imaging revealed a gastric fundus mass, and subtotal gastrectomy confirmed IMT with dense plasma-cell infiltrate and negative ALK immunostaining. We performed single-cell RNA sequencing on tumor and paired adjacent non-tumor tissue (14,103 cells). CellChat analysis inferred prominent CXCL12-CXCR4 communication between neoplastic myofibroblasts and immune cells. Macrophage subclustering identified an S100A9-high inflammatory tumor-associated macrophage state, and pseudotime analysis placed this state along a continuous transcriptional ordering with resident-like macrophages. To our knowledge, this is the first single-cell transcriptomic characterization of pediatric ALK-negative G-IMT and provides hypothesis-generating insight into its inflammatory microenvironment.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Jusen Nong, Weikun Li, Bo Shi
Quelle
Frontiers in Immunology
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
1664-3224
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Jusen Nong, Weikun Li, Bo Shi (2026). Case Report: Single-cell transcriptomic profiling of a pediatric ALK-negative gastric inflammatory myofibroblastic tumor. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1855526
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1